There is a decent chance Essity has been in the room during one of your least public moments. The Swedish company makes products for menstruation, incontinence, wound treatment, compression therapy, handwashing, wiping, baby care and the ordinary business of going to the bathroom. Its wares sit on supermarket shelves and beside hospital beds. They hang on office washroom walls. They are purchased by teenagers, nurses, parents, cleaners, procurement teams and people looking after older relatives.
Yet the corporate name is far less familiar than the brands. TENA is a global name in incontinence care. Tork supplies paper, soap, dispensers and cleaning systems to workplaces and public venues. Libresse, Bodyform, Saba and Nosotras cover period care in different regions. JOBST compression garments, Leukoplast tapes and Cutimed wound dressings live closer to the clinical end of the cabinet. Zewa, Lotus, Tempo, Cushelle and Plenty turn up in kitchens and bathrooms. Essity is the connective tissue, in every sense, behind them.
A young company with old cupboards
Essity is only nine years old on paper. It appeared as an independent company in 2017, when Swedish forest-products group SCA split off and listed its hygiene and health operations. The knowledge underneath is older. SCA entered hygiene through its 1975 purchase of Mölnlycke, a business whose roots stretch to 1849. The new name joined “essentials” and “necessities,” a corporate coinage that is unusually literal.
The separation gave management a cleaner story: no forests, just the products and services attached to human well-being. Essity bought BSN medical in the year of its listing, deepening its position in wound care, compression and orthopedics. It later added Hydrofera, the period-underwear companies Modibodi and Knix, and other regional hygiene businesses. In February 2026 it completed a $340 million purchase of Edgewell’s North American feminine-care operation, bringing Carefree, Stayfree and o.b. in the region, plus global feminine-care rights to Playtex.
“Innovation is a key driver of our competitiveness and growth.”Ulrika Kolsrud, president and CEO, July 2026
That acquisition nearly doubled Essity’s Personal Care presence in North America. It also sharpened the direction of travel. This is still a large tissue manufacturer, but management is allocating attention toward categories where brands, clinical evidence, fit, comfort and specialist knowledge can matter more than the price of a roll.
Four businesses, one human body
Since January 2026, Essity has reported through four business areas. The structure looks tidy on an organization chart. In real life, it follows a person across settings and ages.
Health & Medical
Incontinence care, wounds, compression and orthopedics for patients, caregivers and clinicians.
Personal Care
Period care, retail incontinence, leakproof apparel, baby diapers and skincare.
Consumer Tissue
Toilet paper, towels, tissues, wipes and napkins, including retailer brands.
Professional Hygiene
Tork dispensers, refills, soaps, wipes and data-led cleaning for public spaces.
Health & Medical serves hospitals, care homes, pharmacies, medical-equipment stores and distributors, as well as patients and family caregivers. Personal Care and Consumer Tissue lean heavily on retailers and e-commerce. Professional Hygiene is sold business to business into offices, schools, restaurants, hotels, factories, stadiums, airports and other busy places where an empty soap dispenser becomes an operational problem.
The problems differ, but the shared material science is obvious: manage moisture, protect skin, control leakage, support healing, make a product comfortable enough to use and reliable enough to trust. Add manufacturing expertise, product-safety systems and the ability to move bulky consumables through local supply chains. The result is a portfolio with more internal logic than its shelf locations suggest.
The product is only half the product
At the consumer end, Essity earns money the familiar way: manufacture a repeat-purchase product, build a brand around performance and dignity, then win space in stores and search results. Tissue adds private-label production, which brings scale but less brand protection. Medical products travel through professional recommendation, clinical routines and regulated channels. The professional-hygiene model can be stickier still: place a dispenser in a building, supply the refills and help the cleaning team decide when and where to service it.
Tork’s connected systems illustrate the move from object to workflow. Sensors and usage data can help a facility team service the washroom that needs attention instead of walking a fixed route. In care, sensor technology can support continence routines. These are not software businesses disguised as paper companies. They are physical-product businesses using data to reduce labor, waste and unpleasant surprises.
This helps explain Essity’s difference from a simple commodity manufacturer. Its defenses vary by category: familiar brands in the supermarket; fit, evidence and caregiver education in medical care; and installed dispensers plus service data in professional hygiene. The company also operates across retail, healthcare and institutional channels at a scale few specialists can match. Local and regional production matters because tissue and absorbent products are bulky, freight is expensive, and a supply interruption is immediately visible.
Competing aisle by aisle
There is no single Essity competitor. Kimberly-Clark and Procter & Gamble meet it in consumer tissue and personal care. Sofidel is a force in European tissue. Ontex and Unicharm compete in absorbent hygiene. HARTMANN, Coloplast and Mölnlycke Health Care overlap in parts of medical care. Georgia-Pacific and Kimberly-Clark Professional contest the away-from-home washroom. Retailers’ own labels hover in the background, ready to turn brand loyalty into a price comparison.
Essity’s market position is strongest where the unglamorous detail becomes expertise. The company describes itself as the global leader in incontinence products and professional hygiene, based on its market estimates. Those categories reward a supplier that understands both the user and the person doing the ordering. A discreet pad must work for the wearer. A wound dressing must fit a clinical protocol. A dispenser must survive the Friday-night crowd and still be simple for a cleaner to refill.
The useful lesson: awkward problems are not small markets. They are often large, recurring markets where empathy and precise product design can become commercial advantages.
A portfolio at a crossroads
The numbers show a mature company working for faster growth. Essity posted SEK 138.5 billion in 2025 net sales and SEK 19.6 billion of EBITA excluding items affecting comparability, a 14.1 percent margin. In the second quarter of 2026, sales rose 2.6 percent to SEK 35.1 billion, while organic growth was 0.3 percent. Volume improved, but price and mix moved backward. Adjusted margin was 13.4 percent.
CEO Ulrika Kolsrud, appointed in June 2025 after decades across the company’s value chain, is pushing decision-making into the four business areas. Each now owns more of its innovation, production, marketing and sales. A savings program targets roughly SEK 1 billion in annual savings by the end of 2026, with some of the money intended for growth. The second quarter also brought an example of less visible modernization: Essity said it had deployed an agentic AI tool in procurement and used AI to shorten some product-development lead times.
The largest question sits in the softest part of the portfolio. In May 2026 the board opened a strategic review of Consumer Tissue, a business responsible for 31 percent of 2025 group sales. Options could include a separation, though no decision had been made. Tissue provides scale, household recognition and cash. It is also exposed to fiber and energy costs, private labels and price-sensitive consumers. A different ownership path would leave Essity more concentrated in health, personal care and professional systems.
Dignity as design brief
Essity’s stated purpose is “breaking barriers to well-being.” The line becomes concrete when the barrier is embarrassment, missing information or a public bathroom without supplies. Its Saba and Tork brands work with UNICEF Mexico on handwashing and menstrual health education. Modibodi has partnered with Plan International to improve access to reusable period underwear in rural Laos. In France, Essity has supplied the Red Cross with hygiene kits for people experiencing homelessness.
Environmental work is less optional than it sounds for a company built on fiber, plastic, water, energy and transport. Essity has a validated target for net-zero greenhouse-gas emissions across its value chain by 2050, buys certified wood fiber and works on packaging, waste and lower-carbon production. Recognition from CDP, EcoVadis and the Dow Jones Sustainability Index signals mature systems, not the end of the work. Disposable hygiene solves real health problems while creating a stubborn materials problem. Both truths fit in the same package.
The best way to understand Essity, then, is not as a paper company or a collection of bathroom brands. It is an operator in the infrastructure of ordinary bodies. Its products have to be safe, available, discreet and boringly dependable. When they work, the user can forget them. For Essity, being forgotten at the right moment may be the clearest evidence that the product did its job.